Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus.
Main Authors: | Julio Alonso-Padilla, Marcelo Abril, Belkisyolé Alarcón de Noya, Igor C Almeida, Andrea Angheben, Tania Araujo Jorge, Eric Chatelain, Monica Esteva, Joaquim Gascón, Mario J Grijalva, Felipe Guhl, Alejandro Marcel Hasslocher-Moreno, Manuel Carlos López, Alejandro Luquetti, Oscar Noya, María Jesús Pinazo, Janine M Ramsey, Isabela Ribeiro, Andres Mariano Ruiz, Alejandro G Schijman, Sergio Sosa-Estani, M Carmen Thomas, Faustino Torrico, Maan Zrein, Albert Picado |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-04-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | https://doi.org/10.1371/journal.pntd.0008035 |
Similar Items
-
Characterization and Follow-Up of Trypanosoma cruzi Natural Populations Refractory to Etiological Chemotherapy in Oral Chagas Disease Patients
by: Arturo Muñoz-Calderón, et al.
Published: (2021-04-01) -
Development of Diagnostics for Chagas Disease: Where Should We Put Our Limited Resources?
by: Albert Picado, et al.
Published: (2017-01-01) -
Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity
by: Bianca Zingales, et al.
Published: (2014-09-01) -
Congenital Chagas disease: recommendations for diagnosis, treatment and control of newborns, siblings and pregnant women.
by: Yves Carlier, et al.
Published: (2011-10-01) -
Congenital Chagas disease: an update
by: Yves Carlier, et al.
Published: (2015-05-01)